Details of the Drug

General Information of Drug (ID: DMV7K3Z)

Drug Name

CUTX-101

Synonyms

Copper Histidine; Copper bis(histidinate); UNII-9078K3MO9U; 12561-67-0; 9078K3MO9U; Copper histidinate; Copper bishistidinate; Cu(His)2; L-Histidine, copper complex; Bishistidine copper(II) salt; Bis(L-histidinato-N,O)copper; SCHEMBL895831; DTXSID30154803; Copper, bis(L-histidinato-N,O)-; Copper, bis(L-histidinato-N,N3,O)-; L-Histidine, copper(2+) salt (2:1); Copper, bis(L-histidinato-kappaN,kappaO)-; 13870-80-9; Q27271298

Indication

Disease Entry	ICD 11	Status	REF
Menkes disease	5C64.0	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C12H16CuN6O4
Canonical SMILES: C1=C(NC=N1)CC(C(=O)[O-])N.C1=C(NC=N1)CC(C(=O)[O-])N.[Cu+2]
InChI: 1S/2C6H9N3O2.Cu/c2*7-5(6(10)11)1-4-2-8-3-9-4;/h2*2-3,5H,1,7H2,(H,8,9)(H,10,11);/q;;+2/p-2/t2*5-;/m00./s1
InChIKey: UUYDYUZBCIHUFZ-MDTVQASCSA-L

Cross-matching ID

PubChem CID: 151722
CAS Number: 12561-67-0
TTD ID: DCJ75Y

References

1	Clinical pipeline report, company report or official report of Cyprium Therapeutics.